Biggest News Aggregation in the World
📰 Clinical Program News

Page 12 - Clinical Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Clinical Program. Real-time updates on events, politics, business and more.

Long Term Phase 3 Data Published in Arthritis & Rheumatology Shows LUPKYNIS® (voclosporin) Preserved Kidney Function Up to Three Years in Lupus Nephritis Patients with No New or Unexpected Adverse Events

Aurinia Pharmaceuticals Inc. today announced that full results from the Phase 3, double-blind, placebo-controlled AURORA 2 extension study were published online in Arthritis & Rheumatology, the...
United States Greg Keenan Amit Saxena Aurinia Pharmaceuticals Inc Division Of Rheumatology American College Of Rheumatology

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Infinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab in Patients with Squamous Cell Cancer of the Head and Neck

CAMBRIDGE - Infinity Pharmaceuticals, Inc. , a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming drug candidate, announced...
United Kingdom Ezra Cohen Robert Ilaria Melissa Hackel Infinity Pharmaceuticals Inc Morrow Sodali

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science